The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sonoma Pharmaceuticals (Nasdaq: SNOA) has announced the nationwide retail launch of its advanced HOCl-based burn relief hydrogel in the United States. The product is now available at major retail chains CVS and Walmart, marking a significant expansion of the company's market presence. Designed for the management of minor burns and skin irritations, the hydrogel utilizes the company's proprietary hypochlorous acid technology. Securing distribution in two of the largest U.S. retailers represents a major milestone for Sonoma's consumer healthcare strategy. Analysts expect this move to drive substantial revenue growth and increase brand recognition across the country. This strategic partnership underscores the company's commitment to making its innovative healthcare solutions more accessible to the general public.
Sign up free to access this content
Create Free Account